Departments of Labor, Health and Human Services, and Treasury Take Action to Enhance Prescription Drug Price Transparency

7/1/2025
On May 22, 2025, the Departments of Labor, Health and Human Services, and the Treasury (the Departments) issued a request for information (RFI) regarding improvements to transparency in prescription drug pricing. Specifically, the Departments solicited input about modifying the prescription drug machine-readable file disclosure requirements in the Transparency in Coverage final rules to enhance prescription drug price transparency. The Transparency in Coverage final rules require group health plans and health insurance issuers offering group or individual health insurance coverage to make certain information relating to prescription drug expenditures available to the public. Stakeholder comments to this RFI must be received by July 2, 2025. The Departments also issued an updated FAQ effective May 22, 2025, directed to health plans and health insurance issuers regarding deadlines to enhance file formats so that pricing information is easier for consumers to read and understand. Directives in this guidance include decreasing duplicative data and reducing unnecessary fields to achieve greater price transparency for consumers.
Related Practices: Healthcare Law
Related Attorney: Caroline J. Patterson, Edward J. Yun, Cynthia J. Liba
Related Industry: Healthcare